Loading clinical trials...

UNKNOWNNA

Alio WEAR Study: Long-term Wear of the Alio Platform

NCT06056739•Alio, Inc.

Summary

The WEAR study is long-term interventional study designed to evaluate patient and clinician use of the Alio platform, per its FDA cleared indications.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•At least 18 years of age.
•Receiving hemodialysis via an AVF or AVG in an arm location at the time of study start.
•Able to wear the SmartPatch effectively at the specified location on the arm.
•Ability to understand and sign a written informed consent form, which must be obtained prior to initiation of any study procedures.
•Willing and able to wear the SmartPatch as instructed and comply with all interviews, surveys and questionnaires, and schedule of evaluations.

Exclusion Criteria

•Skin near the proximity of the AV access that is chronically swollen, infected, inflamed, open wounds, lesions, or has skin eruptions.
•Participation in any other clinical trials involving investigational or marketed products that in the opinion of the investigator could affect the quality of the data.
•Other conditions that in the opinion of the Principal Investigator may increase risk to the subject and/or compromise the quality of the clinical trial.

Locations (1)

Site 1

Huntley, Illinois, United States

Key Dates

Start Date

October 9, 2023

Primary Completion Date

April 1, 2024

Completion Date

April 1, 2024

Last Updated

October 11, 2023

Enrollment

250

ESTIMATED participants

Conditions

End Stage Kidney Disease

Interventions

Alio platform

DEVICE

Contacts

Amy Steig

CONTACT

4158348031 amy@alio.ai

Tala Harake

CONTACT

9499235884 tala@alio.ai

Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients

NCT07271420

HypertensionPeritoneal Dialysis+1 more

View study

RECRUITINGPHASE1

Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants

NCT05525507

End Stage Kidney DiseaseImmunological Tolerance+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 11, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Alio WEAR Study: Long-term Wear of the Alio Platform

Inclusion Criteria

Exclusion Criteria

Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients

Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants

Symptom Monitoring in Hemodialysis

Hemodynamics in Chronic Hemodialysis Patients Undergoing Isolated Ultrafiltration Compared to Conventional Hemodialysis

Virtual Reality in Hemodialysis to Improve Psychological Well-being

Immunological Tolerance in Patients With Mismatched Kidney Transplants